Concepedia
1
Publications
11
Citations
H-Index
2022
Active since
Affiliations
Sanofi (France)(Current)
Florie A. Bertrand is an author at Sanofi (France).
Publications per year
2022–2022
Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy
Michaël R. Paillasse, Michaël Esquerré, Florie A. Bertrand et al. · Cancer Research Communications · 2022 · 11 citations · Full text
Rows per page
1–1 of 1